LavaMAX-I

Retatrutide
1 vials x 5 mg

  • Reduces appetite

  • Supports weight loss

  • Helps regulate blood sugar

  • Activates GIP, GLP‑1, and glucagon receptors

LavaMAX-I (Retatrutide) is an investigational oxyntomodulin-based synthetic peptide that functions as a triple agonist targeting the GLP-1, GIP, and glucagon (GCGR) receptors. The insertion of glucagon receptor agonism alongside the two incretin pathways creates a profoundly distinct metabolic state; while GLP-1 and GIP optimize insulin sensitivity and limit food intake, the activation of the glucagon receptor stimulates hepatic lipid turnover, induces direct thermogenesis, and amplifies daily resting energy expenditure.

95%

POPULARITY

Weight-Loss Effect
Nausea During Use
Side-Effect Discontinuation
Do you want to check your product ? Click Here

See Other Products

HUMAXPHARMA

Humaxpharma does not ship to countries, which classify these pharmaceuticals as special controlled or scheduled substances, including but not limited to the United States, Australia, Canada and Europe. We do not sell any products online. We do not sale to the public.
We are not directly or indirectly associated with any websites that may engage in selling same or similar products. Information contained within this website is not a prescription to use and is intended for information purposes only.

Please Note: This website is not an online store. Website does not have a shopping cart or e-commerce features. We do not sell or ship to the USA, Europe, Australia or any other locations where prohibited.

This will close in 20 seconds